TY  - GEN
AU  - Yust-Katz,Shlomit
AU  - Liu,Diane
AU  - Yuan,Ying
AU  - Liu,Vivien
AU  - Kang,Sanghee
AU  - Groves,Morris
AU  - Puduvalli,Vinay
AU  - Levin,Victor
AU  - Conrad,Charles
AU  - Colman,Howard
AU  - Hsu,Sigmonid
AU  - Yung,W K Alfred
AU  - Gilbert,Mark R
TI  - Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma
SN  - 1097-0142
PY  - 2013///1203
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Dacarbazine
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Female
KW  - Glioblastoma
KW  - drug therapy
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Piperidines
KW  - Pyridines
KW  - Supratentorial Neoplasms
KW  - Temozolomide
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cncr.28031
ER  -